Keros Therapeutics (KROS) Shares Issued (2019 - 2025)

Keros Therapeutics has reported Shares Issued for 7 years, with the latest figure at $117000.0 in Q3 2025.

• For the quarter ending Q3 2025, Shares Issued rose 101.35% year-over-year to $117000.0; the trailing twelve-month figure through Dec 2025 stood at $138000.0 (down 98.86% YoY), and the FY2025 full-year result was $138000.0, down 98.86% from the prior year.
• Shares Issued for Q3 2025 stood at $117000.0, up from $17000.0 in the prior quarter.
• The five-year high for Shares Issued was $48.5 million in Q3 2022, with the low at -$57.4 million in Q4 2022.
• Historically, Shares Issued has averaged $879000.0 across 5 years, with a median of $311000.0 in 2023.
• The largest YoY upside for Shares Issued was 49076.77% in 2022 against a maximum downside of 15234.3% in 2022.
• Keros Therapeutics' Shares Issued stood at $379000.0 in 2021, then tumbled by 15234.3% to -$57.4 million in 2022, then jumped by 101.4% to $804000.0 in 2023, then soared by 1410.07% to $12.1 million in 2024, then sank by 99.04% to $117000.0 in 2025.
• The last three Shares Issued figures came in at $117000.0 (Q3 2025), $17000.0 (Q2 2025), and $4000.0 (Q1 2025), per Business Quant data.